SBIR funding within the award tops out at $15 million of the contract value, with a mandatory 1:1 matching requirement consisting of at least 20 percent from non-SBIR DoW program funding and no more than 80 percent from private capital sources
When taken orally, peptide therapys primary indication is gut health helping to repair the gut lining, reduce intestinal inflammation, and support a healthier microbiome
Proper medical oversight ensures optimal benefits and minimizes any potential risks
Each 0.5 fl oz bottle lasts roughly 46 weeks 1% GHK-Cu COPPER PEPTIDE: Formulated with 1% Copper Peptide GHK-Cu for a lightweight, hydrating feel
HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates
The evaluating clinician, not the patient, not the platform, makes the determination of whether therapy is appropriate